Related Experiment Videos
Conformational differences between latent and active plasminogen activator inhibitor, PAI-1: a spectroscopic study
S Boström1, J Deinum, J E Löfroth
1Hässle Cardiovascular Research Laboratories, Mölndal, Sweden.
Thrombosis Research
|September 1, 1990
Summary
Spectroscopic studies reveal distinct protein conformations between latent and active Plasminogen Activator Inhibitor-1 (PAI-1). Latent PAI-1 exhibits a tighter structure with tryptophan residues in a more apolar environment compared to active PAI-1.
Area of Science:
- Biochemistry
- Molecular Biology
- Protein Structure Analysis
Background:
- Plasminogen Activator Inhibitor-1 (PAI-1) exists in active and latent conformational states.
- Understanding these conformational differences is crucial for PAI-1 function and regulation.
Purpose of the Study:
- To investigate and compare the protein conformations of latent and active PAI-1.
- To elucidate the structural basis for the distinct functional states of PAI-1.
Main Methods:
- Circular dichroism spectroscopy (far-UV).
- Absorbance spectroscopy.
- Fluorescence spectroscopy.
Main Results:
- Latent PAI-1 showed a more negative far-UV CD band at 220 nm and a higher absorption maximum (278 nm) compared to active PAI-1.
- Active PAI-1 exhibited a lower absorption maximum (269 nm) that shifted to 274 nm upon denaturation.
- Fluorescence emission maximum was observed at lower wavelengths for latent PAI-1 (335 nm) versus active PAI-1 (340 nm).
Conclusions:
- Spectroscopic data indicate latent PAI-1 possesses a more compact conformation.
- Tryptophan residues in latent PAI-1 are situated in a more apolar environment compared to active PAI-1.
- These findings provide insights into the molecular mechanisms differentiating PAI-1 states.